It indicated that CFT‐1 plays an important role in inhibiting inflammation via regulating NF‐κB pathway, and this may confer HCC resistance during hepatocarcinogenesis induced by NDEA. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.